An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor Patients
EARLY_PHASE1WithdrawnINTERVENTIONAL
0
Timeline
Start Date
March 25, 2022
Primary Completion Date
June 30, 2025
Study Completion Date
December 31, 2025
Conditions
Solid Tumors (Pancreatic Cancer, Esophageal Cancer, Gastric Cancer, Cholangiocarcinoma, Lung Cancer and Ovarian Cancer)